Federico Nichetti

25PUBLICATIONS
166CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 26, 2026
Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy.

|Aug 12, 2026
Performance and Clinical Benefit of Comprehensive Genomic Profiling of GI Tumors in a Comprehensive Cancer Center.

|Dec 30, 2025
FOLFOX Versus FOLFIRI as Second-Line Chemotherapy in Patients With Advanced Biliary Tract Cancers: A Multicenter, Italian Study.

Chiara Pircher, Federico Nichetti, Mario Domenico Rizzato

|Jul 09, 2025
Validating HER2 copy number variation assessment by NGS: A comparative analysis with immunohistochemistry and in situ hybridization.

Daniele Lorenzini, Rebecca Salvatori, Chiara Costanza Volpi

|Jun 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

Federico Nichetti, Marta Brambilla, Matteo Duca

|Dec 02, 2024
The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib/IIa Trial.

Filippo Pietrantonio, Federica Morano, Monica Niger

Pageof 5

Frequent Collaborators

8 joint publications

Monica Niger

5 joint publications

Luca Agnelli

5 joint publications

Filippo Pietrantonio

5 joint publications

Sara Lonardi